Atopic dermatitis (AD) is a common chronic, inflammatory dermatological disorder and skin barrier dysfunction is an early pathology of this condition. Diverse factors contribute to the development of such defects. Skin moisturizers are the mainstay therapy for AD, along with other treatment modalities.

In the present study, dermatologists across India received a questionnaire consisting of questions related to the number of patients seen with AD every week and their clinical experience regarding the use of novel skin moisturizers containing skin barrier therapy for the management of AD. The study analyzed their responses as numbers and percentages.

The study included 1,605 patients and received complete responses from 58 dermatologists. Ninety-eight percent of the dermatologists reported the overall efficacy of novel skin moisturizer (Atoderm Intensive Baume) in AD patients as ′satisfactory′ and found it efficacious in improving various parameters of AD such as skin dryness, the severity of pruritus, inflammation, insomnia, itching and urge to scratch. Furthermore, it was well-tolerated. 

The novel skin moisturizer plays an important role in the repair of damaged skin barriers caused by AD.

These survey findings indicated that a novel skin moisturizer (Atoderm Intensive Baume) is a preferred formulation by dermatologists across India for managing AD with proven efficacy and safety.

Source: Abraham A, Ganjoo A, Kapoor S, et al. Practice pattern and use of a novel skin moisturizer containing skin barrier therapy in patients with atopic dermatitis: a cross-sectional survey among dermatologists in India. Int J Res Dermatol. 2021;7(5):663-7.